TY - JOUR
T1 - Can we improve breast cancer mortality in Okinawa?
T2 - Consensus of the 7th Okinawa Breast Oncology Meeting
AU - The 7th Okinawa Breast Oncology Meeting
AU - The 7th Okinawa Breast Oncology Meeting
AU - Tamaki, Kentaro
AU - Tamaki, Nobumitsu
AU - Kamada, Yoshihiko
AU - Uehara, Kano
AU - Zaha, Hisamitsu
AU - Onomura, Mai
AU - Ueda, Makoto
AU - Kurashita, Kaname
AU - Miyazato, Keiko
AU - Higa, Junko
AU - Miyara, Kyuichiro
AU - Shiraishi, Makiko
AU - Murayama, Shigemi
AU - Ishida, Takanori
AU - Nagamine, Shinji
N1 - Publisher Copyright:
© 2015 Tohoku University Medical Press.
PY - 2015/2/5
Y1 - 2015/2/5
N2 - The rate of breast cancer mortality in Okinawa has gradually been increasing up to 2010. Now Okinawa has the second worst mortality rate in Japan, in part due to the enormous dietary changes resulting from the post-World War II US military occupation, high incidence of obesity, high non-optimal treatment rate, and low breast-cancer screening rate. To reduce breast cancer mortality in Okinawa, we established the Okinawa Breast Oncology Meeting (OBOM) in 2012. At the 7th OBOM held on January 10th, 2014, we discussed the breast cancer mortality in Okinawa focusing on lifestyle, breast cancer screening and optimal treatments. The Okinawan women who were overweight and/or obese during premenopausal and postmenopausal ages had a statistically significant higher risk of breast cancer development compared to those with non-overweight and/or obese women. The traditional diet of Okinawa consists of foods low in calories but rich in nutritional value. Therefore, we recommend Okinawan people not to forget the Okinawan traditional lifestyle, and to reduce their bodyweight to prevent breast cancer. One of the main goals of the OBOM is to raise breast cancer screening attendance rates to 50% (29.2% in 2010). We should standardize the quality control for breast cancer screening in Okinawa. It is important to continue enlightening the Okinawan population to receive optimal treatment. In addition, we are striving to establish systematic medical cooperation between the hospitals specializing in breast cancer treatment with rural hospitals. The OBOM group endeavors to contribute to the improvement of breast cancer mortality in Okinawa.
AB - The rate of breast cancer mortality in Okinawa has gradually been increasing up to 2010. Now Okinawa has the second worst mortality rate in Japan, in part due to the enormous dietary changes resulting from the post-World War II US military occupation, high incidence of obesity, high non-optimal treatment rate, and low breast-cancer screening rate. To reduce breast cancer mortality in Okinawa, we established the Okinawa Breast Oncology Meeting (OBOM) in 2012. At the 7th OBOM held on January 10th, 2014, we discussed the breast cancer mortality in Okinawa focusing on lifestyle, breast cancer screening and optimal treatments. The Okinawan women who were overweight and/or obese during premenopausal and postmenopausal ages had a statistically significant higher risk of breast cancer development compared to those with non-overweight and/or obese women. The traditional diet of Okinawa consists of foods low in calories but rich in nutritional value. Therefore, we recommend Okinawan people not to forget the Okinawan traditional lifestyle, and to reduce their bodyweight to prevent breast cancer. One of the main goals of the OBOM is to raise breast cancer screening attendance rates to 50% (29.2% in 2010). We should standardize the quality control for breast cancer screening in Okinawa. It is important to continue enlightening the Okinawan population to receive optimal treatment. In addition, we are striving to establish systematic medical cooperation between the hospitals specializing in breast cancer treatment with rural hospitals. The OBOM group endeavors to contribute to the improvement of breast cancer mortality in Okinawa.
KW - Breast cancer mortality
KW - Complementary and alternative medicine
KW - Geographic disadvantage
KW - Lifestyle
KW - Screening
UR - http://www.scopus.com/inward/record.url?scp=85000866225&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85000866225&partnerID=8YFLogxK
U2 - 10.1620/tjem.235.111
DO - 10.1620/tjem.235.111
M3 - Article
C2 - 25749491
AN - SCOPUS:85000866225
VL - 235
SP - 111
EP - 115
JO - Tohoku Journal of Experimental Medicine
JF - Tohoku Journal of Experimental Medicine
SN - 0040-8727
IS - 2
ER -